GNXPERT Neural Technologies Inc. – Trademark Portfolio

Entity Type: 03

GNXPERT Neural Technologies Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in Chicago, IL.

2224 West Chicago Avenue

Chicago, IL 60622

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CARDBOOM
CARDBOOM
Abandoned 2004
CARDBOOM
CARDBOOM
Abandoned 2004
GNXPERT
GNXPERT
Abandoned 2003
GNXPERT
GNXPERT
Abandoned 2003

Trademark Classifications

GNXPERT Neural Technologies Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does GNXPERT Neural Technologies Inc. have?

GNXPERT Neural Technologies Inc. has 4 U.S. trademarks filed with the USPTO.

What trademark classes does GNXPERT Neural Technologies Inc. file in?

GNXPERT Neural Technologies Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What is GNXPERT Neural Technologies Inc.'s trademark registration success rate?

GNXPERT Neural Technologies Inc. has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.